← Leaderboards

Juan Enrique Rozengurt

University Of California Los Angeles

Google Scholar ↗PubMed ↗ORCID ↗

$20,476,723

Attributed

$23,300,194

Total exposure

20

Grants

14

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.5M · FY2005–25

$2.5M$1.9M$1.3M$625K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$38,627,821 · 19

VA$0 · 2

By mechanism

P30$20,676,793 · 5

R01$14,489,462 · 6

P01$2,222,553 · 3

R21$1,214,013 · 3

R13$25,000 · 1

P50$0 · 1

Top collaborators

Most similar at University Of California Los Angeles

Same institution · by research overlap

Emeran A Mayer$24,604,323
Jonathan D. Kaunitz$4,687,586
Elaine F Reed$20,661,923
Teresa E Seeman$21,772,630

Others in their field

Top investigators on “Cell Proliferation”

John M Lachin · George Washington University$118,921,924
David M Nathan · Massachusetts Institute Of Technology$118,921,924
David Heimbrook · Leidos Biomedical Research, Inc.$103,164,048
Timothy J Eberlein · Washington University$49,931,668
Deirdre R. Meldrum · University Of Washington$37,202,510
Robert A Weinberg · Whitehead Institute For Biomedical Res$32,735,166

Research focus

Cell ProliferationSignal TransductionCellsPhosphorylationPlayRegulationResponseG-Protein-Coupled ReceptorsProgramsMediatingBaseGrowthIn VivoFamilyIntestinesMouse ModelMigrationPathway InteractionsPreventPathogenesisMalignant NeoplasmsDna BiosynthesisG Protein-Coupled Receptor SignalingPeptides

Grant awards (98)

The role of HLA and its coreceptors in endothelial cell activation and leukocyte recruitment in antibody-mediated transplant rejection$711,793

R01 · FY2025 · AI

Targeting the transcriptional co-activators YAP and TAZ with statins to prevent solid organ transplant rejection by HLA donor specific antibodies$710,735

R01 · FY2025 · AI

The role of HLA and its coreceptors in endothelial cell activation and leukocyte recruitment in antibody-mediated transplant rejection$747,583

R01 · FY2024 · AI

Targeting the transcriptional co-activators YAP and TAZ with statins to prevent solid organ transplant rejection by HLA donor specific antibodies$710,735

R01 · FY2024 · AI

Project 2: Chemoprevention of pancreatic cancer with lipid-lowering and antidiabetic agents$231,495

P01 · FY2024 · CA · contact PI

Targeting the transcriptional co-activators YAP and TAZ with statins to prevent solid organ transplant rejection by HLA donor specific antibodies$723,361

R01 · FY2023 · AI

Project 2: Chemoprevention of pancreatic cancer with lipid-lowering and antidiabetic agents$238,095

P01 · FY2023 · CA · contact PI

Interaction between Chronic Stress and Obesity in Pancreatic Cancer Progression$178,679

R21 · FY2023 · CA · contact PI

Targeting YAP with statins to prevent antibody-mediated transplant rejection$248,864

R21 · FY2022 · AI

Project 2: Chemoprevention of pancreatic cancer with lipid-lowering and antidiabetic agents$238,369

P01 · FY2022 · CA · contact PI

Interaction between Chronic Stress and Obesity in Pancreatic Cancer Progression$218,790

R21 · FY2022 · CA · contact PI

Project 2: Chemoprevention of pancreatic cancer with lipid-lowering and antidiabetic agents$242,953

P01 · FY2021 · CA · contact PI

Targeting YAP with statins to prevent antibody-mediated transplant rejection$195,000

R21 · FY2021 · AI

Identification of the growth-promoting PKD/YAP axis as a novel target for the statins in intestinal epithelial cells.$0

I01 · FY2021 · VA · contact PI

Project 2: Chemoprevention of pancreatic cancer with lipid-lowering and antidiabetic agents$245,814

P01 · FY2020 · CA · contact PI

Identification of the growth-promoting PKD/YAP axis as a novel target for the statins in intestinal epithelial cells.$0

I01 · FY2020 · VA · contact PI

CURE: Digestive Diseases Research Center$927,088

P30 · FY2019 · DK · contact PI

Pilot and Feasibility Program$405,749

P30 · FY2019 · DK · contact PI

Identification of the growth-promoting PKD/YAP axis as a novel target for the statins in intestinal epithelial cells.$0

I01 · FY2019 · VA · contact PI

CURE: Digestive Diseases Research Center$929,695

P30 · FY2018 · DK · contact PI

Pilot and Feasibility Program$384,235

P30 · FY2018 · DK · contact PI

Identification of the growth-promoting PKD/YAP axis as a novel target for the statins in intestinal epithelial cells.$0

I01 · FY2018 · VA · contact PI

CURE: Digestive Diseases Research Center$936,455

P30 · FY2017 · DK · contact PI

Pilot and Feasibility Program$407,622

P30 · FY2017 · DK · contact PI

PKD1 Signaling and Crosstalk Mechanisms in Intestinal Epithelial Cell Regulation$334,950

R01 · FY2017 · DK · contact PI

CURE: Digestive Diseases Research Center$936,455

P30 · FY2016 · DK · contact PI

Pilot and Feasibility Program$407,624

P30 · FY2016 · DK · contact PI

PKD1 Signaling and Crosstalk Mechanisms in Intestinal Epithelial Cell Regulation$334,950

R01 · FY2016 · DK · contact PI

Chemoprevention of pancreatic cancer witli antidiabetic agents$213,210

P01 · FY2016 · CA · contact PI

CURE: Digestive Diseases Research Center$936,455

P30 · FY2015 · DK · contact PI

Pilot and Feasibility Program$407,623

P30 · FY2015 · DK · contact PI

PKD1 Signaling and Crosstalk Mechanisms in Intestinal Epithelial Cell Regulation$334,950

R01 · FY2015 · DK · contact PI

Chemoprevention of pancreatic cancer witli antidiabetic agents$200,663

P01 · FY2015 · CA · contact PI

Calcium-sensing receptor signaling in the regulation of colonic epithelial cells$0

I01 · FY2015 · VA · contact PI

Calcium-sensing receptor signaling in the regulation of colonic epithelial cells$0

I01 · FY2015 · VA · contact PI

CURE: Digestive Diseases Research Center$945,000

P30 · FY2014 · DK · contact PI

ADMINISTRATIVE CORE & ENRICHMENT$492,342

P30 · FY2014 · DK · contact PI

PKD1 Signaling and Crosstalk Mechanisms in Intestinal Epithelial Cell Regulation$334,950

R01 · FY2014 · DK · contact PI

Chemoprevention of pancreatic cancer witli antidiabetic agents$204,626

P01 · FY2014 · CA · contact PI

Calcium-sensing receptor signaling in the regulation of colonic epithelial cells$0

I01 · FY2014 · VA · contact PI

CURE: Digestive Diseases Research Center$878,558

P30 · FY2013 · DK · contact PI

ADMINISTRATIVE CORE & ENRICHMENT$461,832

P30 · FY2013 · DK · contact PI

Chemoprevention of pancreatic cancer witli antidiabetic agents$198,987

P01 · FY2013 · CA · contact PI

CURE: Digestive Diseases Research Center$945,000

P30 · FY2012 · DK · contact PI

ADMINISTRATIVE CORE & ENRICHMENT$483,488

P30 · FY2012 · DK · contact PI

Chemoprevention of pancreatic cancer witli antidiabetic agents$208,341

P01 · FY2012 · CA · contact PI

Calcium-sensing receptor signaling in the regulation of colonic epithelial cells$0

I01 · FY2012 · VA · contact PI

CURE: Digestive Diseases Research Center$929,691

P30 · FY2011 · DK · contact PI

ADMINISTRATIVE CORE & ENRICHMENT$480,426

P30 · FY2011 · DK · contact PI

Gastrointestinal Peptide Signaling through PKC/PKD$320,737

R01 · FY2011 · DK · contact PI

CURE: Digestive Diseases Research Center$945,000

P30 · FY2010 · DK · contact PI

ADMINISTRATIVE CORE & ENRICHMENT$562,308

P30 · FY2010 · DK · contact PI

Gastrointestinal Peptide Signaling through PKC/PKD$323,978

R01 · FY2010 · DK · contact PI

GI PEPTIDE SIGNALING THROUGH TYROSINE PHOSPHORYLATION$268,538

R01 · FY2010 · DK · contact PI

Targeting crosstalk between insulin and Gq signaling systems in pancreatic cancer$203,280

R21 · FY2010 · CA · contact PI

CURE: Digestive Diseases Research Center$99,966

P30 · FY2010 · DK · contact PI

Gastrointestinal Peptide Signaling through PKC/PKD$51,709

R01 · FY2010 · DK · contact PI

CURE: Digestive Diseases Research Center$770,631

P30 · FY2009 · DK · contact PI

Gastrointestinal Peptide Signaling through PKC/PKD$327,250

R01 · FY2009 · DK · contact PI

GI PEPTIDE SIGNALING THROUGH TYROSINE PHOSPHORYLATION$271,251

R01 · FY2009 · DK · contact PI

CURE: DISGESTIVE DISEASES RESEARCH CENTER$255,077

P30 · FY2009 · DK · contact PI

Targeting crosstalk between insulin and Gq signaling systems in pancreatic cancer$169,400

R21 · FY2009 · CA · contact PI

CURE: DIGESTIVE DISEASES RESEARCH CENTER$770,631

P30 · FY2008 · DK · contact PI

Gastrointestinal Peptide Signaling through PKC/PKD$327,250

R01 · FY2008 · DK · contact PI

GI PEPTIDE SIGNALING THROUGH TYROSINE PHOSPHORYLATION$271,251

R01 · FY2008 · DK · contact PI

The International Symposium on Regulatory Peptides$25,000

R13 · FY2008 · DK · contact PI

CURE: DIGESTIVE DISEASES RESEARCH CENTER$770,631

P30 · FY2007 · DK · contact PI

Administrative Core$421,533

P30 · FY2007 · DK · contact PI

Gastrointestinal Peptide Signaling through PKC/PKD$362,822

R01 · FY2007 · DK · contact PI

GI PEPTIDE SIGNALING THROUGH TYROSINE PHOSPHORYLATION$276,787

R01 · FY2007 · DK · contact PI

CURE: DISGESTIVE DISEASES RESEARCH CENTER$793,647

P30 · FY2006 · DK · contact PI

Gastrointestinal Peptide Signaling through PKC/PKD$510,527

R01 · FY2006 · DK · contact PI

GI PEPTIDE SIGNALING THROUGH TYROSINE PHOSPHORYLATION$285,053

R01 · FY2006 · DK · contact PI

CURE: DIGESTIVE DISEASES RESEARCH CENTER$793,647

P30 · FY2005 · DK

Gastrointestinal Peptide Signaling through PKC/PKD$507,274

R01 · FY2005 · DK

CORE A: ADMINISTRATIVE$434,384

P30 · FY2005 · DK

CURE: DIGESTIVE DISEASES RESEARCH CENTER$882,000

P30 · FY2004 · DK

Gastrointestinal Peptide Signaling through PKC/PKD$352,736

R01 · FY2004 · DK

GI PEPTIDE SIGNALING THROUGH TYROSINE PHOSPHORYLATION$315,675

R01 · FY2004 · DK

Gastrointestinal Peptide Signaling through PKC/PKD$138,861

R01 · FY2004 · DK

CURE: DIGESTIVE DISEASES RESEARCH CENTER$882,000

P30 · FY2003 · DK

Gastrointestinal Peptide Signaling through PKC/PKD$347,629

R01 · FY2003 · DK

HORMONAL STIMULATION &INHIBITION OF GASTRIC SECRETION$330,275

R01 · FY2003 · DK

GI PEPTIDE SIGNALING THROUGH TYROSINE PHOSPHORYLATION$315,675

R01 · FY2003 · DK

HORMONAL STIMULATION &INHIBITION OF GASTRIC SECRETION$480,982

R01 · FY2002 · DK

GASTROINTESTINAL PEPTIDE SIGNALING THROUGH PKC/PKD$366,605

R01 · FY2002 · DK

GI PEPTIDE SIGNALING THROUGH TYROSINE PHOSPHORYLATION$316,538

R01 · FY2002 · DK

Neuropeptide signaling antagonists for SCLC therapy$0

P50 · FY2002 · CA

HORMONAL STIMULATION &INHIBITION OF GASTRIC SECRETION$466,972

R01 · FY2001 · DK

GASTROINTESTINAL PEPTIDE SIGNALING THROUGH PKC/PKD$359,210

R01 · FY2001 · DK

GI PEPTIDE SIGNALING THROUGH TYROSINE PHOSPHORYLATION$316,710

R01 · FY2001 · DK

GASTROINTESTINAL PEPTIDE SIGNALING THROUGH PKC/PKD$103,553

R01 · FY2001 · DK

GASTROINTESTINAL PEPTIDE SIGNALING THROUGH PKC/PKD$32,130

R01 · FY2001 · DK

Neuropeptide signaling antagonists for SCLC therapy$0

P50 · FY2001 · CA

HORMONAL STIMULATION &INHIBITION OF GASTRIC SECRETION$461,371

R01 · FY2000 · DK

GASTROINTESTINAL PEPTIDE SIGNALING THROUGH PKC/PKD$349,016

R01 · FY2000 · DK

GI PEPTIDE SIGNALING THROUGH TYROSINE PHOSPHORYLATION$316,710

R01 · FY2000 · DK

GASTROINTESTINAL PEPTIDE SIGNALING THROUGH PKC/PKD$70,380

R01 · FY2000 · DK